Menu
Recruiting NCT07229365

Children's Viewing Behavior

No phase Interventional Myopia Myopia Progression Juvenile Myopia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Novel spectacle lens design, Spectacle lenses.
Who it may be relevant to
Registry conditions: Myopia, Myopia Progression, Juvenile Myopia. Basic parameters: 7 years — 14 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Children's Viewing Behavior in Myopia Control Spectacles

Overview

The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.

Interventions

  • Device Novel spectacle lens design
    Use of lenses may reduce the rate of progression of juvenile myopia
  • Device Spectacle lenses
    Use of lenses may reduce the rate of progression of juvenile myopia

Primary outcome measures

  • Activity dependent, gaze location in myopia control spectacles [Time frame: 2 months]
  • Subjective/objective quantification of activity via survey or observation [Time frame: 2 months]
  • Pupil size [Time frame: 2 months]

Eligibility criteria

Inclusion criteria

A person is eligible for inclusion in the study if he/she:

  • Is 7-14 years of age, inclusive
  • Requires spherical spectacle lenses within the power range available for the study lenses
  • Parent/guardian has read and understood the informed consent form, and the child has provided age-appropriate assent
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best corrected
  • Has had a self-reported oculo-visual examination in the last two years
  • Spectacle cylinder of ≤ -0.75DC in both eyes

Exclusion criteria

A person will be excluded from the study if he/she:

  • Is unable to complete the necessary study activities
  • Has any systemic disease affecting ocular health
  • Is using any systemic or topical medications (including pharmaceutical myopia control therapy) that will affect ocular health
  • Is aphakic

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Single blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Indiana University — Bloomington

Identifiers

NCT: NCT07229365 · CPRO-2507-002

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗